Editas Medicine (EDIT) Total Non-Current Liabilities (2015 - 2025)

Editas Medicine (EDIT) has 10 years of Total Non-Current Liabilities data on file, last reported at $156.4 million in Q4 2025.

• On a quarterly basis, Total Non-Current Liabilities fell 23.41% year-over-year to $156.4 million in Q4 2025; TTM through Dec 2025 was $156.4 million, a 23.41% decrease from a year earlier, with the FY2025 full-year figure at $156.4 million, down 23.41% from the prior year.
• Total Non-Current Liabilities for Q4 2025 stood at $156.4 million, down from $183.6 million in the prior quarter.
• Over the last five years, Total Non-Current Liabilities for EDIT reached as high as $204.2 million in Q4 2024 and fell as low as $142.5 million in Q1 2024.
• Historically, Total Non-Current Liabilities has averaged $166.8 million across 4 years, with a median of $155.0 million in 2022.
• Across the five-year window, Total Non-Current Liabilities jumped 37.76% in 2024 and slipped 23.41% in 2025, its largest moves.
• Year by year, Total Non-Current Liabilities stood at $153.6 million in 2022, then slipped by 3.5% to $148.3 million in 2023, then surged by 37.76% to $204.2 million in 2024, then fell by 23.41% to $156.4 million in 2025.
• Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $156.4 million in Q4 2025, $183.6 million in Q3 2025, and $186.8 million in Q2 2025.